Mycophenolate mofetil for prevention of liver allograft rejection: initial results of a controlled clinical trial.

Abstract

UNLABELLED Mycophenolate Mofetil (M MF) is a new immunosuppressive agent with proven efficacy for the prevention of kidney allograft rejection. However, only little experience is available with the use of MMF in liver transplant recipients. OBJECTIVES In this prospective, controlled trial the efficacy and safety of MMF and Azathioprine (AZA) were compared… (More)

Topics

Cite this paper

@article{Sterneck2000MycophenolateMF, title={Mycophenolate mofetil for prevention of liver allograft rejection: initial results of a controlled clinical trial.}, author={Martina Sterneck and Laurice K Fischer and Christoph G. Gahlemann and Malou Gundlach and Xavier C Rogiers and Cristoph E. Broelsch}, journal={Annals of transplantation}, year={2000}, volume={5 1}, pages={43-6} }